Vir Biotechnology Files Q1 2025 10-Q Report
Ticker: VIR · Form: 10-Q · Filed: May 8, 2025 · CIK: 1706431
| Field | Detail |
|---|---|
| Company | Vir Biotechnology, Inc. (VIR) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotechnology
TL;DR
**VIR Q1 2025 10-Q FILED. CHECK FINANCIALS.**
AI Summary
Vir Biotechnology, Inc. filed its Q1 2025 10-Q report on May 8, 2025, for the period ending March 31, 2025. The company, based in San Francisco, CA, operates in the biological products sector. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Vir Biotechnology, Inc. during the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.
Key Numbers
- Q1 2025 — Reporting Period (The first quarter of fiscal year 2025.)
- 2025-03-31 — End of Reporting Period (The specific date the financial information in the report pertains to.)
- 2024-12-31 — Previous Fiscal Year End (Provides a comparison point for financial trends.)
Key Players & Entities
- Vir Biotechnology, Inc. (company) — Filer of the 10-Q report
- 0001706431 (company) — Central Index Key for Vir Biotechnology, Inc.
- 20250331 (date) — Conformed period of report
- 20250508 (date) — Filing date
- SAN FRANCISCO, CA (location) — Company headquarters location
FAQ
What were Vir Biotechnology's collaboration and contract revenues for Q1 2025 compared to Q1 2024?
The filing indicates Vir Biotechnology, Inc. had collaboration revenue of $XXX for the period 2025-01-01 to 2025-03-31 and $XXX for the period 2024-01-01 to 2024-03-31. Contract revenue was $XXX for 2025-01-01 to 2025-03-31 and $XXX for 2024-01-01 to 2024-03-31. (Note: Specific dollar amounts are not present in the provided text, placeholders are used).
What is the company's fiscal year end?
Vir Biotechnology, Inc.'s fiscal year ends on December 31st.
What is the company's primary business sector?
The company is classified under STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on May 8, 2025.
What is the company's SEC file number?
The SEC file number for Vir Biotechnology, Inc. is 001-39083.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Vir Biotechnology, Inc. (VIR).